Company Filing History:
Years Active: 2005
Title: Peter Gerard Moloney: Innovator in Cannabinoid Receptor Modulation
Introduction
Peter Gerard Moloney is a notable inventor based in West Brunswick, Australia. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with cannabinoid receptors. His work is characterized by a focus on creating innovative solutions for pain management.
Latest Patents
Peter Gerard Moloney holds a patent for "3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives." This invention provides aminoalkylindole compounds of Formula (I), wherein R-R, n, and p are as described. The patent also includes compositions containing these compounds and their use in modulating the activity of cannabinoid receptors in subjects. Specifically, the invention highlights the potential of these compounds as analgesic agents.
Career Highlights
Peter is associated with Amrad Operations Pty Ltd, where he has been instrumental in advancing research and development in cannabinoid-related therapies. His innovative approach has led to the creation of compounds that may offer new avenues for pain relief.
Collaborations
Peter has worked alongside Alan Duncan Robertson, contributing to the collaborative efforts in the field of medicinal chemistry. Their partnership has fostered advancements in the understanding and application of cannabinoid receptor modulation.
Conclusion
Peter Gerard Moloney's contributions to the field of cannabinoid receptor modulation exemplify the impact of innovative thinking in medicinal chemistry. His patent and ongoing work continue to pave the way for new therapeutic options in pain management.